Authors
Latest:
Developing Your Roadmap to Pharma 4.0Questions to ask before transitioning into new technologies. By Yvonne Duckworth and Cory Perelman.
Latest:
Exploring the Digital Therapeutics LandscapeObservations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton
Latest:
Reducing Risk in the Pharmaceutical Cold ChainWhen delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.
Latest:
What is a Digital Hub in 2023?Deciphering the different "technology-first” and “technology-enabled” patient support programs.
Latest:
Seeing the Value of Scientific ContentLeveraging the value healthcare professionals place on scientific content
Latest:
Strategizing High-Wire, Multi-Indication LaunchesProperly supporting market access for a newly launched product with a single indication is challenging. Doing so for multiple indications, or supporting subsequent indications, can have a compounding effect on the degree of difficulty for getting everything right.
Latest:
Chatbot Potential in Clinical ResearchHow AI-powered support automation can solve the data problem in clinical trial management
Latest:
Is Trust the Secret Ingredient for Digital Product Success?To rebuild trust, companies should utilize a customer-centric approach, focusing on transparent and neutral content incorporating medical expertise and regularly seeking HCP feedback.
Latest:
Global Logistics: A Cold Chain BlueprintThe growing pipeline of cold chain products holds tremendous promise for patients, but can result in failed shipments if not properly planned for
Latest:
Why Multimodal Data is Growing in PharmaMaking connections between different datasets is essential to developing impactful medicines and driving more personalized patient care.
Latest:
Flipping the Switch on DSCSA InteroperabilityFrom November 2023, the Drug Supply Chain Security Act requires healthcare manufacturers, distributors, providers, and dispensers to exchange the serialized item-level product information that has been collected, standardized, and digitized. Hitting this deadline hinges on intensive collaboration between manufacturers and their supply chain partners that must begin now
Latest:
No More Excuses: It’s Time to Invest in the PharmacyOrganizations can go a long way toward ushering in the pharmacy of the future and enabling safer, more efficient care by implementing an intelligent infrastructure of technology.
Latest:
Questions Patient Access Leaders Should Be Asking About AI (But Aren’t)Conversation with chief tech expert explores AI’s rise in the support space—and separating the substance from the noise.
Latest:
Rethinking NCPs in support mixNon-commercial pharmacies can be secret weapons for intake and adherence
Latest:
The Opportunity for SustainabilityPharma’s prime chance to reduce carbon emissions from supply chain
Latest:
Achieving Efficient, Optimized, and Compliant Production at ScaleInnovation in pharma manufacturing as paradigms shift and biotech and personalized therapies move through clinical trials at pace
Latest:
Patient Data: Solving Ownership QuestionHow privacy and technology literacy can coexist behind a blockchain-based approach to patient data analytics and control
Latest:
Your Trusted Resource for Mission Critical SolutionsThere’s a reason your facility’s most sensitive operations are called “mission critical.” Learn how ABM’s highly technical management services can take the worry out of maintaining your most specialized systems.
Latest:
How State Privacy Laws Are Shaping DTC and HCP Marketing StrategiesWhy they are a game changer, and ways to a adapt to a new era of state privacy regulations.
Latest:
Creating a Future-Ready Chemicals and Materials Lab Vital for GrowthTeams need to keep close track of ingredients, processing parameters, and material performance so that they can use their R&D data to decide exactly which materials to make next.
Latest:
FDA Gives Alzheimer’s Drug Leqembi Full Approval. That Means Medicare Coverage But...Medicare-eligible patients need to be enrolled in registry to get Medicare coverage for the anti-beta amyloid drug that is priced to cost $26,500 a year.
Latest:
Shipping Strategies in Unusual TimesThe steps pharma manufacturers can take to mitigate transportation costs amid Covid’s supply-chain crunch
Latest:
Expert: Digital Transformation is Key Part of Biopharma C-Suite Goals for 2024Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.
Latest:
Unique Challenges to Market Access for Ophthalmology BiosimilarsCatherine Humphries sheds light on three key market access challenges within the ophthalmology biosimilars space.
Latest:
Insurance Barriers Delaying Patient CareWhy it’s time to act on passing key bills to boost access for millions.
Latest:
Machine Health in Pharmaceutical ProductionPredictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
Latest:
Reshaped Priorities Pave Cold Chain PathHow recent advancements in practice and technology have ushered in a new era of pharmaceutical logistics.
Latest:
Beyond the Hype: GenAI’s Real Impact on Life Sciences ManufacturingTaking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.
